529 related articles for article (PubMed ID: 14641843)
1. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843
[TBL] [Abstract][Full Text] [Related]
2. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination.
Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK
Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508
[TBL] [Abstract][Full Text] [Related]
3. Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis.
Ramaiah KD; Das PK; Vanamail P; Pani SP
Trans R Soc Trop Med Hyg; 2007 Jun; 101(6):555-63. PubMed ID: 17374389
[TBL] [Abstract][Full Text] [Related]
4. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.
Bockarie MJ; Alexander ND; Hyun P; Dimber Z; Bockarie F; Ibam E; Alpers MP; Kazura JW
Lancet; 1998 Jan; 351(9097):162-8. PubMed ID: 9449870
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled community trial of four cycles of single-dose diethylcarbamazine or ivermectin against Wuchereria bancrofti infection and transmission in India.
Das PK; Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Balarajan K; Bundy DA
Trans R Soc Trop Med Hyg; 2001; 95(3):336-41. PubMed ID: 11491011
[TBL] [Abstract][Full Text] [Related]
6. Effect of annual mass administration of diethylcarbamazine and albendazole on bancroftian filariasis in five villages in south India.
Ramaiah KD; Vanamail P; Yuvaraj J; Das PK
Trans R Soc Trop Med Hyg; 2011 Aug; 105(8):431-7. PubMed ID: 21601901
[TBL] [Abstract][Full Text] [Related]
7. Community-based trial of annual versus biannual single-dose ivermectin plus albendazole against Wuchereria bancrofti infection in human and mosquito populations: study protocol for a cluster randomised controlled trial.
de Souza DK; Ahorlu CS; Adu-Amankwah S; Otchere J; Mensah SK; Larbi IA; Mensah GE; Biritwum NK; Boakye DA
Trials; 2017 Oct; 18(1):448. PubMed ID: 28969715
[TBL] [Abstract][Full Text] [Related]
8. Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.
Vanamail P; Ramaiah KD; Subramanian S; Pani SP; Yuvaraj J; Das PK
Ann Trop Med Parasitol; 2005 Apr; 99(3):237-42. PubMed ID: 15829133
[TBL] [Abstract][Full Text] [Related]
9. Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.
Jambulingam P; Subramanian S; de Vlas SJ; Vinubala C; Stolk WA
Parasit Vectors; 2016 Sep; 9(1):501. PubMed ID: 27624157
[TBL] [Abstract][Full Text] [Related]
10. Lymphatic filariasis transmission in Rufiji District, southeastern Tanzania: infection status of the human population and mosquito vectors after twelve rounds of mass drug administration.
Jones C; Ngasala B; Derua YA; Tarimo D; Reimer L; Bockarie M; Malecela MN
Parasit Vectors; 2018 Nov; 11(1):588. PubMed ID: 30424781
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of lymphatic filariasis in a tea garden worker population of Dibrugarh (Assam), India after six rounds of mass drug administration.
Khan AM; Dutta P; Sarmah CK; Baruah NK; Das S; Pathak AK; Sarmah P; Hussain ME; Mahanta J
J Vector Borne Dis; 2015 Dec; 52(4):314-20. PubMed ID: 26714512
[TBL] [Abstract][Full Text] [Related]
12. Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatment on transmission of Wuchereria bancrofti in East Sepik Province.
Bockarie MJ; Ibam E; Alexander ND; Hyun P; Dimber Z; Bockarie F; Alpers MP; Kazura JW
P N G Med J; 2000; 43(3-4):172-82. PubMed ID: 11939298
[TBL] [Abstract][Full Text] [Related]
13. Changes in Wuchereria bancrofti infection in a highly endemic community following 10 rounds of mass administration of diethylcarbamazine.
Ramaiah KD; Vanamail P; Das PK
Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):250-5. PubMed ID: 16890256
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of the use of vector control and mass drug administration, separately or in combination, against lymphatic filariasis.
Krishnamoorthy K; Rajendran R; Sunish IP; Reuben R
Ann Trop Med Parasitol; 2002 Dec; 96 Suppl 2():S77-90. PubMed ID: 12625921
[TBL] [Abstract][Full Text] [Related]
15. Molecular xenomonitoring as a post-MDA surveillance tool for global programme to eliminate lymphatic filariasis: Field validation in an evaluation unit in India.
Subramanian S; Jambulingam P; Krishnamoorthy K; Sivagnaname N; Sadanandane C; Vasuki V; Palaniswamy C; Vijayakumar B; Srividya A; Raju HKK
PLoS Negl Trop Dis; 2020 Jan; 14(1):e0007862. PubMed ID: 31978060
[TBL] [Abstract][Full Text] [Related]
16. Decline in lymphatic filariasis transmission with annual mass drug administration using DEC with and without albendazole over a 10year period in India.
Sunish IP; Kalimuthu M; Rajendran R; Munirathinam A; Ashok Kumar V; Nagaraj J; Tyagi BK
Parasitol Int; 2015 Feb; 64(1):1-4. PubMed ID: 25205435
[TBL] [Abstract][Full Text] [Related]
17. Elimination of lymphatic filariasis as a public health problem from the Arab Republic of Egypt.
Ramzy RMR; Kamal HA; Hassan MA; Haggag AA
Acta Trop; 2019 Nov; 199():105121. PubMed ID: 31400299
[TBL] [Abstract][Full Text] [Related]
18. How Does the Proportion of Never Treatment Influence the Success of Mass Drug Administration Programs for the Elimination of Lymphatic Filariasis?
Kura K; Stolk WA; Basáñez MG; Collyer BS; de Vlas SJ; Diggle PJ; Gass K; Graham M; Hollingsworth TD; King JD; Krentel A; Anderson RM; Coffeng LE
Clin Infect Dis; 2024 Apr; 78(Supplement_2):S93-S100. PubMed ID: 38662701
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis.
Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL
Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704
[TBL] [Abstract][Full Text] [Related]
20. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
